These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 54718)

  • 41. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection.
    Kaijser B
    J Infect Dis; 1973 Jun; 127(6):670-7. PubMed ID: 4196446
    [No Abstract]   [Full Text] [Related]  

  • 42. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.
    Frosch M; Görgen I; Boulnois GJ; Timmis KN; Bitter-Suermann D
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1194-8. PubMed ID: 3919387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological activity of a surface component of Neisseria meningitidis.
    Vedros NA
    Prog Immunobiol Stand; 1971; 5():472-7. PubMed ID: 4633973
    [No Abstract]   [Full Text] [Related]  

  • 44. [Proteins with heterologous determinants in the somatic antigens of Enterobacteriaceae].
    Barber C; Eylan E
    Rev Immunol (Paris); 1972; 36(4):137-44. PubMed ID: 4125996
    [No Abstract]   [Full Text] [Related]  

  • 45. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.
    Kasper DL; Winkelhake JL; Brandt BL; Artenstein MS
    J Infect Dis; 1973 Apr; 127(4):378-87. PubMed ID: 4121052
    [No Abstract]   [Full Text] [Related]  

  • 46. Purification of Escherichia coli K antigens.
    Vann WF; Freese SJ
    Methods Enzymol; 1994; 235():304-11. PubMed ID: 8057903
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sialic acid-containing polysaccharides of Neisseria meningitidis and Escherichia coli strain Bos-12: structure and immunology.
    Liu TY; Gotschlich EC; Egan W; Robbins JB
    J Infect Dis; 1977 Aug; 136 Suppl():S71-7. PubMed ID: 408434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.
    Brandt BL; Wyle FA; Artenstein MS
    J Immunol; 1972 Apr; 108(4):913-20. PubMed ID: 4623401
    [No Abstract]   [Full Text] [Related]  

  • 50. The colicin K of Escherichia coli K235.
    Goebel WF; Tsao SS
    Ann Immunol Hung; 1972; 16(0):131-43. PubMed ID: 4213421
    [No Abstract]   [Full Text] [Related]  

  • 51. Binding diversity of monoclonal antibodies to alpha(2-->8) polysialic acid conjugated to outer membrane vesicle via adipic acid dihydrazide.
    Devi SJ; Karpas AB; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jul; 14(4):211-20. PubMed ID: 8856320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An immunochemical analysis of the dissociation of the beta2 component of Escherichia coli tryptophan synthetase.
    Mills SE; Baron-Murphy J; Rocha V; Crawford I
    Arch Biochem Biophys; 1973 May; 156(1):365-72. PubMed ID: 4125890
    [No Abstract]   [Full Text] [Related]  

  • 53. Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.
    Argaman M; Liu TY; Robbins JB
    J Immunol; 1974 Feb; 112(2):649-55. PubMed ID: 4205205
    [No Abstract]   [Full Text] [Related]  

  • 54. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.
    Orskov F; Orskov I; Sutton A; Schneerson R; Lin W; Egan W; Hoff GE; Robbins JB
    J Exp Med; 1979 Mar; 149(3):669-85. PubMed ID: 372481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acid sequence of the FV region of a human monoclonal IgM (NOV) with specificity for the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1, which cross-reacts with polynucleotides and with denatured DNA.
    Gawinowicz MA; Merlini G; Birken S; Osserman EF; Kabat EA
    J Immunol; 1991 Aug; 147(3):915-20. PubMed ID: 1907308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative evaluation of the methods of monitoring the activity of diagnostic meningococcal group-specific sera].
    Ereshchenko VV; Petrova ZS; Zhukova LF
    Lab Delo; 1982; (9):567-9. PubMed ID: 6183530
    [No Abstract]   [Full Text] [Related]  

  • 57. Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.
    Moore SL; Uitz C; Ling CC; Bundle DR; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Oct; 14(10):1311-7. PubMed ID: 17804612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigenic relationship between Escherichia coli and Neisseria meningitidis.
    Grados O; Ewing WH
    J Infect Dis; 1970; 122(1):100-3. PubMed ID: 4988472
    [No Abstract]   [Full Text] [Related]  

  • 59. [Isolation of an agglutinating anti-E. coli K 88+ serum].
    Petkov M; Belchev K; Ganovski D
    Vet Med Nauki; 1981; 18(1):27-31. PubMed ID: 6171087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers.
    Frasch CE; Chapman SS
    J Infect Dis; 1973 Feb; 127(2):149-54. PubMed ID: 4632041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.